Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ING2 | Q9H160 | 1/20 | 0.48 |
| ▸ | NT5E | P21589 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.45 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.44 |
| ▸ | NSD2 | O96028 | 4/20 | 0.42 |
| ▸ | CASP6 | P55212 | 4/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.42 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30057851 | 1.00 | ING2 (0.48) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL30999 | 1.00 | ING2 (0.48) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL9242875 | 1.00 | ING2 (0.48) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL772208 | 1.00 | ING2 (0.48) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL3309996 | 0.98 | ING2 (0.47) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL17627830 | 0.98 | ING2 (0.47) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| Water SCHEMBL7784437 | 0.98 | ING2 (0.47) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL772207 | 0.98 | ING2 (0.47) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL30989279 | 0.98 | ING2 (0.47) | ING2NT5EALDH1A1HSD17B10PRMT1 | |
| SCHEMBL9960463 | 0.98 | ING2 (0.47) | ING2NT5EALDH1A1HSD17B10PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 755 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060614-A | Yeast extract without precipitate after compatibility with cetyl trimethyl ammonium bromide, and preparation and application thereof | 安琪酵母股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260097379-A1 | Methods of Making Nanomaterial Dispersions and Nanocomposite Materials Produced by Dispersion Methods | UNIV BROWN (US) | 2026-04-09 | — | — | US | claimed |
| EP-4720322-A2 | ENZYME-CATALYZED REGIOSELECTIVE POLYMERIZATION FOR PREPARATION OF LINEAR POLYLYSINE OR POLYARGININE | BASF SE (DE) | 2026-04-08 | — | — | EP | claimed |
| US-20260007571-A1 | PHARMACEUTICAL CONTAINER WITH PH PROTECTIVE LAYER DEPOSITED BY ATOMIC LAYER DEPOSITION | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2026-01-08 | — | — | US | claimed |
| WO-2025245470-A1 | SYRINGE WITH BUILT-IN LUBRICATION FOR MEDICAL USE | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| US-12447107-B2 | Pharmaceutical container with pH protective layer deposited by atomic layer deposition | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-10-21 | — | — | US | claimed |
| US-20250248896-A1 | PHARMACEUTICAL CONTAINER WITH PH PROTECTIVE LAYER DEPOSITED BY ATOMIC LAYER DEPOSITION | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-08-07 | — | — | US | claimed |
| EP-4054334-B1 | COMPOSITIONS, USES AND METHODS FOR PREVENTION AND TREATMENT OF VIRAL PLANT INFECTIONS | HW INNOVATIONS B V (NL) | 2025-07-30 | — | — | EP | claimed |
| CN-119776327-B | Collagenase mutant, gene fragment, recombinant plasmid, recombinant expression system and application thereof, and method for preparing collagenase mutant and collagen tripeptide | 上海锴泰生物科技有限公司 | 2025-06-03 | — | — | CN | claimed |
| US-12303461-B1 | Pharmaceutical container with pH protective layer deposited by atomic layer deposition | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-05-20 | — | — | US | claimed |
| EP-4168068-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SiO2 Medical Products, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| EP-4149520-A1 | METHODS AND COMPOSITIONS FOR ATI DIGESTION | Glutagen Pty Ltd (AU) | 2023-03-22 | — | — | EP | claimed |
| CN-115382494-A | Production process for preventing diesel tail gas treatment liquid from generating flocculent suspended matters or sediments | 溢通环保科技（莆田）有限公司 | 2022-11-25 | — | — | CN | claimed |
| EP-4054334-A1 | COMPOSITIONS, USES AND METHODS FOR PREVENTION AND TREATMENT OF VIRAL PLANT INFECTIONS | HW Innovations B.V. (NL) | 2022-09-14 | — | — | EP | claimed |
| US-20220227838-A1 | COVALENT MODIFICATION OF BIOLOGICAL MACROMOLECULES | MOSAIC BIOSCIENCES, INC. | 2022-07-21 | — | — | US | claimed |
| CN-114630888-A | Method for reducing malodor on fabrics | 宝洁公司 | 2022-06-14 | — | — | CN | claimed |
| CN-112449651-B | Treatment compositions comprising low levels of oligoamines | 宝洁公司 | 2022-06-07 | — | — | CN | claimed |
| CN-110731021-B | Separator for lithium-sulfur battery, method for preparing same, and lithium-sulfur battery comprising same | 株式会社LG新能源 | 2022-05-10 | — | — | CN | claimed |
| US-20220133627-A1 | Stable Therapeutic Formulations | ALZA CORP (US) | 2022-05-05 | — | — | US | claimed |
| CN-107849596-B | High-purity collagen particles and preparation method and application thereof | 亚果生医股份有限公司 | 2022-02-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007571-A1 | PHARMACEUTICAL CONTAINER WITH PH PROTECTIVE LAYER DEPOSITED BY ATOMIC LAYER DEPOSITION | CFD, SLC9B2, SETD1B | ING2 3739/4885NT5E 3709/4885ALDH1A1 773/4885 |
| US-20220227838-A1 | COVALENT MODIFICATION OF BIOLOGICAL MACROMOLECULES | PTMS, EPCAM, SUMO3 | ING2 4510/4885NT5E 2630/4885ALDH1A1 507/4885 |
| US-20260097379-A1 | Methods of Making Nanomaterial Dispersions and Nanocomposite Materials Produced by Dispersion Methods | ACR, VCL, PRNP | ING2 1574/4885NT5E 2180/4885ALDH1A1 3257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.